Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03232931 · ClinicalTrials.gov registry record · NA
Trial to Improve Multisensory Neural Processing, Language & Motor Outcomes in Preterm Infants
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 248
- Enrollment target
NCT03232931: Completed NA study, sponsored by Emory University.
NCT03232931 is a NA study that has completed, run by Emory University. The registered enrollment target is 248 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03232931, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
Study Summary
Every year, almost all of ½ million infants born prematurely in the US and 15 million worldwide suffer from abnormal brain maturation resulting from interactions between immaturity and atypical sensory experiences after birth. This study uses rigorous scientific methods to measure the effects and determine the mechanisms of action of a parent-supported multisensory neurorehabilitative intervention for preterm infants, adaptable to a wide variety of neonatal environments, even when parents cannot be at their child's bedside. The intervention aims to improve brain multisensory processing, reactions to sensory stimulation in the home and long term language and motor development.
Primary Outcome
Cortical processing is measured as the percentage of time spent in Event Related Potential (ERP) response patterns that have been previously characterized as typical in healthy infants born at full term. ERP is assessed through high-density functional electroencephalogram (EEG) in the NICU. The Index of Multisensory Processing (IMP) is calculated as the percentage of time that the topographical pattern of the participant's ERP to multisensory stimuli is most like template map of a full term infa
Interventions
- BEHAVIORAL Therapist skin-to-skin Care
- DEVICE Contingent parent's voice exposure
- BEHAVIORAL Parental skin-to-skin care
- DEVICE Recorded parent's voice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2018-10-29 |
| Est. Completion | 2025-04-25 |
| Phase | NA |
What the finished NCT03232931 record still lists
NCT03232931 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 4 interventions - of which Therapist skin-to-skin Care is the first listed.
NCT03232931 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03232931 about?
NCT03232931 is a clinical study titled "Trial to Improve Multisensory Neural Processing, Language & Motor Outcomes in Preterm Infants". Every year, almost all of ½ million infants born prematurely in the US and 15 million worldwide suffer from abnormal brain maturation resulting from interactions between immaturity and atypical sensory experiences after birth. This study uses rigorous scientific methods to measure the effects and de...
What is the current status of trial NCT03232931?
This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2018-10-29. Estimated completion is 2025-04-25.
What interventions are being tested in trial NCT03232931?
The interventions under investigation include: Therapist skin-to-skin Care (BEHAVIORAL), Contingent parent's voice exposure (DEVICE), Parental skin-to-skin care (BEHAVIORAL), Recorded parent's voice (DEVICE).
Who is sponsoring clinical trial NCT03232931?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03232931's enrollment target sits among peer trials
248 434th of 2000 higher than 1,565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI